Intensity Therapeutics, Inc. Made Big Gain
Thu, Oct 30, 2025 at 07:16 PM
Intensity Therapeutics, Inc. (INTS:NASDAQ) rocketted at $1.32, representing a gain of 394.6%. On Thu, Oct 30, 2025, INTS:NASDAQ touched a New 2-Week High of $1.32. The stock got featured on our News Catalysts scanner on Thu, Oct 30, 2025 at 09:24 AM in the 'BIOTECH' category. From Thu, Oct 16, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Oct 30, 2025 at $1.74 with a volume of 1B+.
About Intensity Therapeutics, Inc. (INTS:NASDAQ)
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers.
Top 10 Gainers:
- Intensity Therapeutics, Inc. (INTS:NASDAQ), 394.57%
- Boqii Holding Limited (BQ:NYSEMKT), 113.73%
- Movella Holdings Inc. (MVLA:NASDAQ), 100%
- Hempacco Co., Inc. (HPCO:NASDAQ), 80%
- Charming Medical Limited (MCTA:NASDAQ), 45.04%
- Aqua Metals, Inc. (AQMS:NASDAQ), 41.21%
- Harvard Bioscience, Inc. (HBIO:NASDAQ), 41.1%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- Emergent BioSolutions Inc. (EBS:NYSE), 36.6%
- Global Engine Group Holding Limited (GLE:NASDAQ), 35.91%